117 related articles for article (PubMed ID: 31561002)
1. Glucocorticoid resistance of allogeneic T cells alters the gene expression profile in the inflamed small intestine of mice suffering from acute graft-versus-host disease.
Li H; Kaiser TK; Borschiwer M; Bohnenberger H; Reichardt SD; Lühder F; Walter L; Dressel R; Meijsing SH; Reichardt HM
J Steroid Biochem Mol Biol; 2019 Dec; 195():105485. PubMed ID: 31561002
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids attenuate acute graft-versus-host disease by suppressing the cytotoxic capacity of CD8(+) T cells.
Theiss-Suennemann J; Jörß K; Messmann JJ; Reichardt SD; Montes-Cobos E; Lühder F; Tuckermann JP; AWolff H; Dressel R; Gröne HJ; Strauß G; Reichardt HM
J Pathol; 2015 Mar; 235(4):646-55. PubMed ID: 25358639
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids delivered by inorganic-organic hybrid nanoparticles mitigate acute graft-versus-host disease and sustain graft-versus-leukemia activity.
Kaiser TK; Li H; Roßmann L; Reichardt SD; Bohnenberger H; Feldmann C; Reichardt HM
Eur J Immunol; 2020 Aug; 50(8):1220-1233. PubMed ID: 32133644
[TBL] [Abstract][Full Text] [Related]
4. The Potential Genes Mediate the Pathogenicity of Allogeneic CD4
Yu Z; Qin C; Cao M; He X; Ren H; Liu H
Biomed Res Int; 2021; 2021():9958745. PubMed ID: 34036106
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.
Wang Z; Ma K; Liu C; Hu X; Que W; Ito H; Takahashi K; Nakajima M; Tanaka T; Ren K; Guo WZ; Yi SQ; Li XK
Drug Discov Ther; 2021 Jan; 14(6):304-312. PubMed ID: 33390570
[TBL] [Abstract][Full Text] [Related]
6. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
[TBL] [Abstract][Full Text] [Related]
7. IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation.
Gong H; Ma S; Liu S; Liu Y; Jin Z; Zhu Y; Song Y; Lei L; Hu B; Mei Y; Liu H; Liu Y; Wu Y; Dong C; Xu Y; Wu D; Liu H
Front Immunol; 2018; 9():2724. PubMed ID: 30534126
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease.
Wen Q; Xu ZL; Wang Y; Lv M; Song Y; Lyv ZS; Xing T; Xu LP; Zhang XH; Huang XJ; Kong Y
Sci China Life Sci; 2023 Mar; 66(3):528-544. PubMed ID: 36166182
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis of thymocytes during acute graft-versus-host disease is independent of glucocorticoids.
Krenger W; Rossi S; Holländer GA
Transplantation; 2000 May; 69(10):2190-3. PubMed ID: 10852622
[TBL] [Abstract][Full Text] [Related]
11. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
Toubai T; Tanaka J; Nishihira J; Ohkawara T; Hirate D; Kondo N; Tone S; Shono Y; Ibata M; Sugita J; Kato N; Miura Y; Iwao N; Ota S; Imamura M
Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715
[TBL] [Abstract][Full Text] [Related]
12. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
13. Tissue-Specific Expression Patterns of MicroRNA during Acute Graft-versus-Host Disease in the Rat.
Jalapothu D; Boieri M; Crossland RE; Shah P; Butt IA; Norden J; Dressel R; Dickinson AM; Inngjerdingen M
Front Immunol; 2016; 7():361. PubMed ID: 27695455
[TBL] [Abstract][Full Text] [Related]
14. miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation.
Lee CW; Wohlan K; Dallmann I; Förster R; Ganser A; Krueger A; Scherr M; Eder M; Koenecke C
J Immunol; 2016 May; 196(9):3927-34. PubMed ID: 27009493
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin E ameliorates acute graft-versus-host disease by modulating Th17 cell subsets and inhibiting STAT3 activation.
Kim SY; Park MJ; Kwon JE; Jung KA; Jhun JY; Lee SY; Seo HB; Ryu JY; Beak JA; Choi JY; Cho ML
Immunol Lett; 2018 Nov; 203():62-69. PubMed ID: 30240636
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
17. Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either Agent Alone.
Al-Homsi AS; Goodyke A; McLane M; Abdel-Mageed S; Cole K; Muilenburg M; Feng Y
Biol Blood Marrow Transplant; 2017 Feb; 23(2):255-261. PubMed ID: 27888016
[TBL] [Abstract][Full Text] [Related]
18. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
19. Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.
Luo X; Xu L; Li Y; Tan H
Cell Biol Toxicol; 2017 Apr; 33(2):169-181. PubMed ID: 27770236
[TBL] [Abstract][Full Text] [Related]
20. Hsp90 inhibition ameliorates CD4
Berges C; Kerkau T; Werner S; Wolf N; Winter N; Hünig T; Einsele H; Topp MS; Beyersdorf N
Immun Inflamm Dis; 2016 Dec; 4(4):463-473. PubMed ID: 27980780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
